BACKGROUND: Retroelements (REs) occupy a significant part of all eukaryotic genomes including humans. The majority of retroelements in the human genome are inactive and unable to retrotranspose. Dozens of active copies are repressed in most normal tissues by various cellular mechanisms. These copies can become active in normal germline and brain tissues or in cancer, leading to new retroposition events. The consequences of such events and their role in normal cell functioning and carcinogenesis are not yet fully understood. If new insertions occur in a small portion of cells they can be found only with the use of specific methods based on RE enrichment and high-throughput sequencing. The downside of the high sensitivity of such methods is the presence of various artifacts imitating real insertions, which in many cases cannot be validated due to lack of the initial template DNA. For this reason, adequate assessment of rare (< 1%) subclonal cancer specific RE insertions is complicated. RESULTS: Here we describe a new copy-capture technique which we implemented in a method called SeqURE for Sequencing Unknown of Retroposition Events that allows for efficient and reliable identification of new genomic RE insertions. The method is based on the capture of copies of target molecules (copy-capture), selective amplification and sequencing of genomic regions adjacent to active RE insertions from both sides. Importantly, the template genomic DNA remains intact and can be used for validation experiments. In addition, we applied a novel system for testing method sensitivity and precisely showed the ability of the developed method to reliably detect insertions present in 1 out of 100 cells and a substantial portion of insertions present in 1 out of 1000 cells. Using advantages of the method we showed the absence of somatic Alu insertions in colorectal cancer samples bearing tumor-specific L1HS insertions. CONCLUSIONS: This study presents the first description and implementation of the copy-capture technique and provides the first methodological basis for the quantitative assessment of RE insertions present in a small portion of cells.

5 1 Kulakov National Medical Research Center for Obstetrics Gynecology and Perinatology Moscow Russia

Central European Institute of Technology Masaryk University Brno Czech Republic

Dmitry Rogachev National Medical and Research Center of Pediatric Hematology Oncology and Immunology Moscow Russia

Engelhardt Institute of Molecular Biology Russian Academy of Sciences Moscow Russia

Ryzhikh National Medical Research Centre for Coloproctology of the Ministry of Health of Russia Moscow Russia

Shemyakin Ovchinnikov Institute of Bioorganic Chemistry Moscow Russia

Zobrazit více v PubMed

Penzkofer T, Jäger M, Figlerowicz M, Badge R, Mundlos S, Robinson PN, et al. L1Base 2: more retrotransposition-active LINE-1s, more mammalian genomes. Nucleic Acids Res. 2017;45:D68–D73. doi: 10.1093/nar/gkw925. PubMed DOI PMC

Feusier J, Watkins WS, Thomas J, Farrell A, Witherspoon DJ, Baird L, et al. Pedigree-based estimation of human mobile element retrotransposition rates. Genome Res. 2019;29:1567–1577. doi: 10.1101/gr.247965.118. PubMed DOI PMC

Kazazian HH, Moran JV. Mobile DNA in health and disease. N Engl J Med. 2017;377:361–370. doi: 10.1056/NEJMra1510092. PubMed DOI PMC

Burns KH. Transposable elements in cancer. Nat Rev Cancer. 2017;17:415–424. doi: 10.1038/nrc.2017.35. PubMed DOI

Helman E, Lawrence MS, Stewart C, Sougnez C, Getz G, Meyerson M. Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing. Genome Res. 2014;24:1053–1063. doi: 10.1101/gr.163659.113. PubMed DOI PMC

Tubio JMC, Li Y, Ju YS, Martincorena I, Cooke SL, Tojo M, et al. Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science. 2014;345:1251343. doi: 10.1126/science.1251343. PubMed DOI PMC

Schauer SN, Carreira PE, Shukla R, Gerhardt DJ, Gerdes P, Sanchez-Luque FJ, et al. L1 retrotransposition is a common feature of mammalian hepatocarcinogenesis. Genome Res. 2018;28:639–653. doi: 10.1101/gr.226993.117. PubMed DOI PMC

Coufal NG, Garcia-Perez JL, Peng GE, Yeo GW, Mu Y, Lovci MT, et al. L1 retrotransposition in human neural progenitor cells. Nature. 2009;460:1127–1131. doi: 10.1038/nature08248. PubMed DOI PMC

Evrony GD, Cai X, Lee E, Hills LB, Elhosary PC, Lehmann HS, et al. Single-neuron sequencing analysis of L1 retrotransposition and somatic mutation in the human brain. Cell. 2012;151:483–496. doi: 10.1016/j.cell.2012.09.035. PubMed DOI PMC

Kano H, Godoy I, Courtney C, Vetter MR, Gerton GL, Ostertag EM, et al. L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev. 2009;23:1303–1312. doi: 10.1101/gad.1803909. PubMed DOI PMC

van den Hurk JAJM, Meij IC, del Carmen Seleme M, Kano H, Nikopoulos K, Hoefsloot LH, et al. L1 retrotransposition can occur early in human embryonic development. Hum Mol Genet. 2007;16:1587–1592. doi: 10.1093/hmg/ddm108. PubMed DOI

Erwin JA, Marchetto MC, Gage FH. Mobile DNA elements in the generation of diversity and complexity in the brain. Nat Rev Neurosci. 2014;15:497–506. doi: 10.1038/nrn3730. PubMed DOI PMC

Kurnosov AA, Ustyugova SV, Nazarov VI, Minervina AA, Komkov AY, Shugay M, et al. The evidence for increased L1 activity in the site of human adult brain neurogenesis. PLoS One. 2015;10:e0117854. doi: 10.1371/journal.pone.0117854. PubMed DOI PMC

Upton KR, Gerhardt DJ, Jesuadian JS, Richardson SR, Sánchez-Luque FJ, Bodea GO, et al. Ubiquitous L1 mosaicism in hippocampal neurons. Cell. 2015;161:228–239. doi: 10.1016/j.cell.2015.03.026. PubMed DOI PMC

Goubert C, Thomas J, Payer LM, Kidd JM, Feusier J, Watkins WS, et al. TypeTE: a tool to genotype mobile element insertions from whole genome resequencing data. Nucleic Acids Res. 2020;48:e36. doi: 10.1093/nar/gkaa074. PubMed DOI PMC

Rodriguez-Martin B, Alvarez EG, Baez-Ortega A, Zamora J, Supek F, Demeulemeester J, et al. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. Nat Genet. 2020;52:306–319. doi: 10.1038/s41588-019-0562-0. PubMed DOI PMC

Loh JW, Ha H, Lin T, Sun N, Burns KH, Xing J. Integrated Mobile element scanning (ME-scan) method for identifying multiple types of polymorphic mobile element insertions. Mob DNA. 2020;11:12. doi: 10.1186/s13100-020-00207-x. PubMed DOI PMC

Tang Z, Steranka JP, Ma S, Grivainis M, Rodić N, Huang CRL, et al. Human transposon insertion profiling: analysis, visualization and identification of somatic LINE-1 insertions in ovarian cancer. Proc Natl Acad Sci U S A. 2017;114:E733–E740. doi: 10.1073/pnas.1619797114. PubMed DOI PMC

Ewing AD, Gacita A, Wood LD, Ma F, Xing D, Kim M-S, et al. Widespread somatic L1 retrotransposition occurs early during gastrointestinal cancer evolution. Genome Res. 2015;25:1536–1545. doi: 10.1101/gr.196238.115. PubMed DOI PMC

Kvikstad EM, Piazza P, Taylor JC, Lunter G. A high throughput screen for active human transposable elements. BMC Genomics. 2018;19:115. doi: 10.1186/s12864-018-4485-4. PubMed DOI PMC

Komkov AY, Minervina AA, Nugmanov GA, Saliutina MV, Khodosevich KV, Lebedev YB, et al. An advanced enrichment method for rare somatic retroelement insertions sequencing. Mob DNA. 2018;9:31. doi: 10.1186/s13100-018-0136-1. PubMed DOI PMC

Mamedov IZ, Arzumanyan ES, Amosova AL, Lebedev YB, Sverdlov ED. Whole-genome experimental identification of insertion/deletion polymorphisms of interspersed repeats by a new general approach. Nucleic Acids Res. 2005;33:e16. doi: 10.1093/nar/gni018. PubMed DOI PMC

Evrony GD, Lee E, Park PJ, Walsh CA. Resolving rates of mutation in the brain using single-neuron genomics. Elife. 2016;5. PubMed PMC

Nugmanov GA, Komkov AY, Saliutina MV, Minervina AA, Lebedev YB, Mamedov IZ. A pipeline for the error-free identification of somatic Alu insertions in high-throughput sequencing data. Mol Biol (Mosk) 2019;53:154–165. doi: 10.1134/S0026893319010114. PubMed DOI

Kivioja T, Vähärautio A, Karlsson K, Bonke M, Enge M, Linnarsson S, et al. Counting absolute numbers of molecules using unique molecular identifiers. Nat Methods. 2011;9:72–74. doi: 10.1038/nmeth.1778. PubMed DOI

Sudmant PH, Rausch T, Gardner EJ, Handsaker RE, Abyzov A, Huddleston J, et al. An integrated map of structural variation in 2,504 human genomes. Nature. 2015;526:75–81. doi: 10.1038/nature15394. PubMed DOI PMC

Mir AA, Philippe C, Cristofari G. euL1db: the European database of L1HS retrotransposon insertions in humans. Nucleic Acids Res. 2015;43:D43–D47. doi: 10.1093/nar/gku1043. PubMed DOI PMC

Pitkänen E, Cajuso T, Katainen R, Kaasinen E, Välimäki N, Palin K, et al. Frequent L1 retrotranspositions originating from TTC28 in colorectal cancer. Oncotarget. 2014;5:853–859. doi: 10.18632/oncotarget.1781. PubMed DOI PMC

Shukla R, Upton KR, Muñoz-Lopez M, Gerhardt DJ, Fisher ME, Nguyen T, et al. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell. 2013;153:101–111. doi: 10.1016/j.cell.2013.02.032. PubMed DOI PMC

Cajuso T, Sulo P, Tanskanen T, Katainen R, Taira A, Hänninen UA, et al. Retrotransposon insertions can initiate colorectal cancer and are associated with poor survival. Nat Commun. 2019;10:4022. doi: 10.1038/s41467-019-11770-0. PubMed DOI PMC

Mamedov I, Batrak A, Buzdin A, Arzumanyan E, Lebedev Y, Sverdlov ED. Genome-wide comparison of differences in the integration sites of interspersed repeats between closely related genomes. Nucleic Acids Res. 2002;30:e71. doi: 10.1093/nar/gnf071. PubMed DOI PMC

Stewart C, Kural D, Strömberg MP, Walker JA, Konkel MK, Stütz AM, et al. A comprehensive map of mobile element insertion polymorphisms in humans. PLoS Genet. 2011;7:e1002236. doi: 10.1371/journal.pgen.1002236. PubMed DOI PMC

Lee E, Iskow R, Yang L, Gokcumen O, Haseley P, Luquette LJ, et al. Landscape of somatic retrotransposition in human cancers. Science. 2012;337:967–971. doi: 10.1126/science.1222077. PubMed DOI PMC

Baillie JK, Barnett MW, Upton KR, Gerhardt DJ, Richmond TA, De Sapio F, et al. Somatic retrotransposition alters the genetic landscape of the human brain. Nature. 2011;479:534–537. doi: 10.1038/nature10531. PubMed DOI PMC

The Absence of Retroelement Activity Is Characteristic for Childhood Acute Leukemias and Adult Acute Lymphoblastic Leukemia